Εμφανίζονται 1 - 20 Αποτελέσματα από 134 για την αναζήτηση '"митральный клапан"', χρόνος αναζήτησης: 1,97δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal

    Συνεισφορές: The study was carried out on the basis of the Federal State Budgetary Institution "Research Institute of Complex Issues of Cardiovascular Diseases", within the framework of the fundamental topic No. 0419-2022-0002 "Development of innovative models for managing the risk of developing diseases of the circulatory system, taking into account comorbidity, based on the study of fundamental, clinical, epidemiological mechanisms and organizational technologies of medical care in the industrial region of Siberia".

    Πηγή: Complex Issues of Cardiovascular Diseases; Том 14, № 5 (2025); 16-26 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 14, № 5 (2025); 16-26 ; 2587-9537 ; 2306-1278

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1573/1087; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1573/1854; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1573/1855; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1573/1856; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1573/1857; Barbarash O.L., Odarenko Yu.N., Kondyukova N.V. Quality of life indicators in evaluating the efficiency of surgical treatment in patients with acquired heart diseases undergoing bioprosthetic and mechanical heart valve replacement. Creative Cardiology. 2019;13(1):28‒39. doi:10.24022/1997-3187-2019-13-1-28-39. (in Russian); IPDAS 2005: Criteria for judging the quality of patient decision aids. International Patient Decision Aids Standards (IPDAS) Collaboration. http://ipdas.ohri.ca/ipdas_checklist.pdf (accessed 07 November 2024); Bermudez T, Bierbauer W, Scholz U, Hermann M. Depression and anxiety in cardiac rehabilitation: differential associations with changes in exercise capacity and quality of life. Anxiety Stress Coping. 2022 Mar;35(2):204-218. doi:10.1080/10615806.2021.1952191; Goruleva M. V., Ganenko O. S., Коvaltcova R. S., Kutuzova A., Petrova N. N., Demchemnko E. A., Nedoshivin A. O. Quality of life and psycho-cognitive condition in patients after coronary artery bypass graft surgery. Russian Journal of Cardiology. 2014;9(113):68‒71. https://doi.org/10.15829/1560-4071-2014-9-68-71 (in Russian); Bubnova M.G. Relevant problems of participation and education of patients in cardiac rehabilitation and secondary prevention programs. Cardiovascular Therapy and Prevention. 2020;19(6):2649. doi:10.15829/1728-8800-2020-2649. (in Russian); Zheleznev S.I., Demidov D.P., Afanasiev A.V., Nazarov V.M., Demin I.I., Bogachev-Prokofiev A.V., Astapov D.A., Karaskov A.M. Radiofrequency denervation of pulmonary artery in surgery of dysplastic mitral valve defects with severe pulmonary hypertension. Russian Journal of Cardiology. 2016;11(139):70‒72. doi:10.15829/1560-4071-2016-11-70-72. (in Russian); Avdeev S.N., Barbarash O.L., Valieva Z.S., Volkov A.V., Veselova T.N., Galyavich A.S., Goncharova N.S., Gorbachevsky S.V., Gramovich V.V., Danilov N.M., Klimenko A.A., Martynyuk T.V., Moiseeva O.M., Ryzhkova D.V., Simakova M.A., Sinitsyn V. E., Stukalova O. V., Chazova I. E., Chernogrivov I. E., Shmalts A. A., Tsareva N.A. 2024 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology. 2024;29(11):6161. doi:10.15829/1560-4071-2024-6161.; Thomson Mangnall L.J., Gallagher R.D., Sibbritt D.W., Fry M.M. Health-related quality of life of patients after mechanical valve replacement surgery: an integrative review. Eur. J. Cardiovasc. Nurs. 2015 Feb;14(1):16‒25. doi:10.1177/1474515114528126.; Bazylev V.V., Nemchenko E.V., Abramova G.N., Kanaeva T.V., Karnakhin V.A. Quality of life after surgical treatment of mitral heart disease. Cardiosomatics. 2020;11(4):30‒35. doi:10.26442/22217185.2020.4.200553. (in Russian); Muthukrishnan A, Tayyib N.A, Alsolami F.J, Ramaiah P, Lathamangeswaric C. Anxiety and quality of life outcomes after coronary artery bypass graft surgery - a prospective cohort study. Curr. Probl. Cardiol. 2023;48(2):101474. doi:10.1016/j.cpcardiol.2022.101474.; Guzelhan Y, Conkbayir C, Ugurlucan M, Yildiz C.E, Alpagut U, Bozbuga N. Gender differences in patients with anxiety after coronary artery bypass surgery. Heart Surg. Forum. 2018;21(3):E165-E169. doi:10.1532/hsf.1451.; Shostak N.A., Klimenko A.N., Shemenkova V.S., Svet A.V. Use of the SF-36 questionnaire in assessment of quality of life in patients with chronic thromboembolic pulmonary hypertension. The Clinician. 2017;11(3-4):44‒49. doi:10.17650/1818-8338-2017-11-3-4-44-49. (in Russian); Sale A, Yu J. Quality of life instruments in atrial fibrillation: a systematic review of measurement properties. Health Qual Life Outcomes. 2022;20(1):143. doi:10.1186/s12955-022-02057-y.; Bockeria O.L., Yurkulieva G.A. Effectiveness and impact of modern af-treatment methods on quality of life in patients with different forms of atrial fibrillation. Annals of Arrhythmology. 2017;14(4):211‒220. doi:10.15275/annaritmol.2017.4.4. (in Russian); Goldsmith I.R., Lip G.Y., Patel R.L. A prospective study of changes in the quality of life of patients following mitral valve repair and replacement. Eur. J. Cardiothorac. Surg. 2001;20(5):949–955. doi:10.1016/S1010-7940(01)00952-6.; Ay Y, Kara I, Aydin C, Ay N.K., Inan B, Basel H, Zeybek R. Comparison of the health related quality of life of patients following mitral valve surgicalprocedures in the 6- months follow-up: a prospective study. Ann. Thorac. Cardiovasc. Surg. 2013;19(2):113–119. doi:10.5761/atcs.oa.12.02234.; Sedrakyan A., Vaccarino V., Elefteriades J.A., et al. Health related quality of life after mitral valve repairs and replacements. Qual. Life Res. 2006;15(7):1153–1160. doi:10.1007/s11136-006-0055-3.; Immer F.E., Donati O., Wyss T., et al. Quality of life after mitral valve surgery: differences between reconstruction and replacement. J. Heart Valve Dis. 2003;12(2):162–168.; Balasubramanian A, Larive AB, Horn EM, DuBrock HM, Mehra R, Jacob MS, Hemnes AR, Leopold JA, Radeva MK, Hill NS, Erzurum SC, Rosenzweig EB, Frantz RP, Rischard FP, Beck GJ, Hassoun PM, Mathai SC; PVDOMICS Study Group. Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension. Chest. 2024 ;165(6):1493-1504. doi:10.1016/j.chest.2024.02.009.; Gorbunova E.V., Rozhnev V.V., Lyapina I.N., Barbarash O.L. Dynamics of adherence to treatment and quality of life in patients with prosthetic heart valves who participated in the educational programs (10-year follow-up). Complex Issues of Cardiovascular Diseases. 2022;11(1):69-77. (In Russian) https://doi.org/10.17802/2306-1278-2022-11-1-69-77

  3. 3
    Academic Journal

    Συνεισφορές: Авторы заявляют об отсутствии финансирования исследования.

    Πηγή: Complex Issues of Cardiovascular Diseases; Том 13, № 4 (2024); 35-46 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 13, № 4 (2024); 35-46 ; 2587-9537 ; 2306-1278

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1489/951; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1489/1665; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1489/1666; Kim K. M., Arghami A., Habib R., Daneshmand M. A., Parsons N., Elhalabi Z., Krohn C., Thourani V., Bowdish M. E. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2022 Update on Outcomes and Research. Ann Thorac Surg. 2023;115(3):566-574. doi:10.1016/j.athoracsur.2022.12.033.; Emren Z.Y., Emren S.V., Kılıçaslan B., Solmaz H., Susam İ., Sayın .A, Abud B., Aydın M., Bayturan Ö. Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease. J Cardiothorac Surg. 2014;9:153. doi:10.1186/s13019-014-0153-1.; Iung B. Interface between valve disease and ischaemic heart disease. Heart. 2000;84(3):347-52. doi:10.1136/heart.84.3.347.; Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005-11. doi:10.1016/S0140-6736(06)69208-8.; Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS); Vahanian A., Alfieri O., Andreotti F., Antunes M.J., Barón-Esquivias G., Baumgartner H., Borger M.A., Carrel T.P., De Bonis M., Evangelista A. et al. , Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451-96. doi:10.1093/eurheartj/ehs109.; Nanjappa M.C., Ananthakrishna R., Hemanna Setty S.K., Bhat P., Shankarappa R.K., Panneerselvam A., Kamalapurkar G., Bhat S.P., Rao V.R. Acute severe mitral regurgitation following balloon mitral valvotomy: echocardiographic features, operative findings, and outcome in 50 surgical cases. Catheter Cardiovasc Interv. 2013;81(4):603-8. doi:10.1002/ccd.24417.; Castleberry A.W., Williams J.B., Daneshmand M.A., Honeycutt E., Shaw L.K., Samad Z., Lopes R.D., Alexander J.H., Mathew J.P., Velazquez E.J., Milano C.A., Smith P.K. Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience. Circulation. 2014 Jun 17;129(24):2547-56. doi:10.1161/CIRCULATIONAHA.113.005223.; Chan K.M., Punjabi P.P., Flather M., Wage R., Symmonds K., Roussin I., Rahman-Haley S., Pennell D.J., Kilner P.J., Dreyfus G.D., Pepper J.R.; RIME Investigators. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012;126(21):2502-10. doi:10.1161/CIRCULATIONAHA.112.143818.; Michler R.E., Smith P.K., Parides M.K., Ailawadi G., Thourani V., Moskowitz A.J., Acker M.A., Hung J.W., Chang H.L., Perrault L.P., Gillinov A.M., Argenziano M., Bagiella E., Overbey J.R., Moquete E.G., Gupta L.N., Miller M.A., Taddei-Peters W.C., Jeffries N., Weisel R.D., Rose E.A., Gammie J.S., DeRose J.J.Jr., Puskas J.D., Dagenais F., Burks S.G., El-Hamamsy I., Milano C.A., Atluri P., Voisine P., O'Gara P.T., Gelijns A.C.; CTSN. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. N Engl J Med. 2016;374(20):1932-41. doi:10.1056/NEJMoa1602003.; Salmasi M.Y., Harky A., Chowdhury M.F., Abdelnour A., Benjafield A., Suker F., Hubbard S., Vohra H.A. Should the mitral valve be repaired for moderate ischemic mitral regurgitation at the time of revascularization surgery? J Card Surg. 2018;33(7):374-384. doi:10.1111/jocs.13722.; Белов Ю.В., Катков А.И., Винокуров И.А. , Стоногин А.В., Комаров Р.Н. Продолжительность искусственного кровообращения как предиктор ранних результатов после операции на сердце. Хирургия. 2015;(5):4-13. doi:10.17116/hirurgia201554-13.; Al-Ruzzeh S., Nakamura K., Athanasiou T., Modine T., George S., Yacoub M., Ilsley C., Amrani M. Does off-pump coronary artery bypass (OPCAB) surgery improve the outcome in high-risk patients?: a comparative study of 1398 high-risk patients. Eur J Cardiothorac Surg. 2003;23(1):50-5. doi:10.1016/s1010-7940(02)00654-1.; Raja S.G., Husain M., Salhiyyah K., Navaratnarajah M., Chudasama D., Walker C.P., Amin F., Amrani M. Concomitant off-pump coronary artery bypass grafting results in improved in-hospital outcomes for patients with ischemic mitral regurgitation undergoing surgery. Heart Surg Forum. 2013;16(1):E15-20. doi:10.1532/HSF98.20121039.; Al-Sarraf N., Thalib L., Hughes A., Houlihan M., Tolan M., Young V., McGovern E. Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients. Int J Surg. 2011;9(1):104-9. doi:10.1016/j.ijsu.2010.10.007.; Zavolozhin A., Shonbin A., Bystrov D., Enginoev S. Mitral valve surgery combined with on-pump versus off-pump myocardial revascularization: A prospective randomized analysis with midterm follow-up. J Card Surg. 2020;35(10):2649-2656. doi:10.1111/jocs.14861.; Demal T.J., Fehr S., Mariscalco G., Reiter B., Bibiza E., Reichenspurner H., Gatti G., Onorati F., Faggian G., Salsano A. et al. Coronary Artery Bypass Grafting in Patients With High Risk of Bleeding. Heart Lung Circ. 2022;31(2):263-271. doi:10.1016/j.hlc.2021.06.519.; Nadeem R., Agarwal S., Jawed S., Yasser A., Altahmody K. Impact of Cardiopulmonary Bypass Time on Postoperative Duration of Mechanical Ventilation in Patients Undergoing Cardiovascular Surgeries: A Systemic Review and Regression of Metadata. Cureus. 2019;11(11):e6088. doi:10.7759/cureus.6088.

  4. 4
  5. 5
  6. 6
  7. 7
    Academic Journal

    Πηγή: Siberian Journal of Clinical and Experimental Medicine; Том 39, № 2 (2024); 46-57 ; Сибирский журнал клинической и экспериментальной медицины; Том 39, № 2 (2024); 46-57 ; 2713-265X ; 2713-2927

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.sibjcem.ru/jour/article/view/2307/960; Mil-Homens Luz F., Amorim M.J. Ischemic mitral regurgitation – to repair or replace? Looking beyond the valve. Port. J. Card. Thorac. Vasc. Surg. 2022;29(1):25–34. DOI:10.48729/pjctvs.253.; Calafiore A.M., Prapas S., Katsavrias K., Totaro A., Di Marco M., Guarracini S. et al. Ischemic mitral regurgitation: Changing rationale of reparative surgical strategy. Hellenic J. Cardiol. 2021;62(1):35–37. DOI:10.1016/j.hjc.2020.12.003.; Beeri R. Ischemic mitral regurgitation and leaflet remodeling: Another arrow hits the target. J. Am. Coll. Cardiol. 2022;80(5):511–512. DOI:10.1016/j.jacc.2022.05.023.; Servito T., Elbatarny M., Yanagawa B., Dokollari A., Bisleri G. Surgical repair of ischemic mitral regurgitation: One ring does not fit all. Curr. Opin. Cardiol. 2021;36(2):154–162. DOI:10.1097/HCO.0000000000000827.; Hickey M.S., Smith L.R., Muhlbaier L.H., Harrell F.E. Jr., Reves J.G., Hinohara T. et al. Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation. 1988;78(3_Pt_2):I51–I59.; Nonaka D.F., Fox A.A. Ischemic mitral regurgitation: Repair, replacement or nothing. Semin. Cardiothorac. Vasc. Anesth. 2019;23(1):11–19. DOI:10.1177/1089253218792921.; Burch G.E., De Pasquale N.P., Phillips J.H. The syndrome of papillary muscle dysfunction. Am. Heart. J. 1968;75(3):399–415. DOI:10.1016/0002-8703(68)90097-5.; Vinciguerra M., Grigioni F., Romiti S., Benfari G., Rose D., Spadaccio C. et al. Ischemic mitral regurgitation: A multifaceted syndrome with evolving therapies. Biomedicines. 2021;9(5):447. DOI:10.3390/biomedicines9050447.; Vinciguerra M., Romiti S., Wretschko E., D’Abramo M., Rose D., Miraldi F. et al. Mitral plasticity: The way to prevent the burden of ischemic mitral regurgitation? Front. Cardiovasc. Med. 2022;8:794574. DOI:10.3389/fcvm.2021.794574.; Yamazaki S., Numata S., Yaku H. Surgical intervention for ischemic mitral regurgitation: How can we achieve better outcomes? Surg. Today. 2020;50(6):540–550. DOI:10.1007/s00595-019-01823-8.; Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P. 3rd, Gentile F. et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: Executive summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):е35– е71. DOI:10.1161/CIR.000000000000932.; Piatkowski R., Kochanowski J., Budnik M., Peller M., Grabowski M., Opolski G. Stress echocardiography protocol for deciding type of surgery in ischemic mitral regurgitation: Predictors of mitral regurgitation recurrence following CABG alone. J. Clin. Med. 2021;10(21):4816. DOI:10.3390/jcm10214816.; Hadjadj S., Marsit O., Paradis J.M., Beaudoin J. Pathophysiology, diagnosis, and new therapeutic approaches for ischemic mitral regurgitation. Can. J. Cardiol. 2021;37(7):968–979. DOI:10.1016/j.cjca.2020.12.011.; Бузиашвили Ю.И., Кокшенева И.В., Абуков С.Т., Абдуллаев А.А. Значение функции папиллярных мышц митрального клапана и прилежащих сегментов миокарда левого желудочка в прогрессировании ишемической митральной регургитации у больных ишемической болезнью сердца после хирургического лечения. Терапевтический архив. 2015;87(8):915. DOI:10.17116/terarkh20158789-15.; Carpentier A. Cardiac valve surgery – the “French correction”. J. Thorac. Cardiovasc. Surg. 1983;86(3):323–337.; Schaff H.V., Nguyen A. Contemporary techniques for mitral valve repair – the Mayo Clinic experience. Indian J. Thorac. Cardiovasc. Surg. 2020;36(Suppl_1):18–26. DOI:10.1007/s12055-019-00801-6.; Kuralay E. Mitral ring annuloplasty by biological material. Turk. Gogus. Kalp. Damar. Cerrahisi. Derg. 2022;30(4):645–648. DOI:10.5606/tgkdc.dergisi.2022.23578.; Chotivatanapong T. Mitral annuloplasty ring design and selection: Complete semi-rigid is best. JTCVS Tech. 2021;10:55–57. DOI:10.1016/j.xjtc.2021.10.036.; Del Forno B., Castiglioni A., Sala A., Geretto A., Giacomini A., Denti P. et al. Mitral valve annuloplasty: Tutorial (video). Multimed. Man. Cardiothorac. Surg. 2017:016. DOI:10.1510/mmcts.2017.016.; Pierce E.L., Bloodworth C.H., Imai A., Begum S., Soomro M.A., Naseeb Kh. et al. Mitral annuloplasty ring flexibility preferentially reduces posterior suture forces. J. Biomech. 2018;75:58–66. DOI:10.1016/j.jbiomech.2018.04.043.; Kubota K., Otsuji Y., Ueno T. et al. Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation: importance of subvalvular tethering in the mechanism and dynamic deterioration during exertion. J. Thorac. Cardiovasc. Surg. 2010;140(3):617–623. DOI:10.1016/j.jtcvs.2009.11.00342.; Bertrand P.B., Gutermann H., Smeets C.J., Van Kerrebroeck C., Verhaert D., Vandervoort P. et al. Functional impact of transmitral gradients at rest and during exercise after restrictive annuloplasty for ischemic mitral regurgitation. J. Thorac. Cardiovasc. Surg. 2014;148(1):183–187. DOI:10.1016/j.jtcvs.2013.10.013.; Bertrand P.B., Verbrugge F.H., Verhaert D., Smeets C.J., Grieten L., Mullens W. et al. Mitral valve area during exercise after restrictive mitral valve annuloplasty: Importance of diastolic anterior leaflet tethering. J. Am. Coll. Cardiol. 2015;65(5):452–461. DOI:10.1016/j.jacc.2014.11.037.; Penicka M., Linkova H., Lang O. et al. Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery. Circulation. 2009;120(15):1474–1481. DOI:10.1161/CIRCULATIONAHA.108.842104.; Braun J., Bax J.J., Versteegh M.I., Voigt P.G., Holman E.R., Klautz R.J. et al. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur. J. Cardiothorac. Surg. 2005;27(5):847–853. DOI:10.1016/j.ejcts.2004.12.031.; Jeong D.S., Lee H.Y., Kim W.S., Sung K., Park P.W., Lee Y.T. Off pump coronary artery bypass versus mitral annuloplasty in moderate ischemic mitral regurgitation. Ann. Thorac. Cardiovasc. Surg. 2012;18(4):322– 330. DOI:10.5761/atcs.oa.11.01845.; Fattouch K., Sampognaro R., Speziale G. et al. Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting. Ann. Thorac. Surg. 2010;90(4):1187–1194. DOI:10.1016/j.athoracsur.2010.03.103.; Sun X., Huang J., Shi M., Huang G., Pang, L., Wang Y. Predictors of moderate ischemic mitral regurgitation improvement after off-pump coronary artery bypass. J. Thorac. Cardiovasc. Surgery. 2015;149(6):1606– 1612. DOI:10.1016/j.jtcvs.2015.02.047.; Poh K.K., Lee G.K., Lee L.C., Chong E., Chia B.L., Yeo T.C. Reperfusion therapies reduce ischemic mitral regurgitation following inferoposterior ST-segment elevation myocardial infarction. Coron. Artery. Dis. 2012;23(8):555–559. DOI:10.1097/MCA.0b013e32835aab65.; Hwang H.Y., Lim J.H., Oh S.J., Paeng J.C., Kim K.B. Improved functional mitral regurgitation after off-pump revascularization in acute coronary syndrome. Ann. Thorac. Surg. 2012;94(4):1157–1165. DOI:10.1016/j.athoracsur.2012.04.118.; Capoulade R., Zeng X., Overbey J.R. et al. Impact of left ventricular to mitral valve ring mismatch on recurrent ischemic mitral regurgitation after ring annuloplasty. Circulation. 2016;134(17):1247–1256. DOI:10.1161/CIRCULATIONAHA.115.021014.; Magne J., Pibarot P., Dagenais F., Hachicha Z., Dumesnil J.G., Sénéchal M. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation. 2007;115(6):782–791. DOI:10.1161/CIRCULATIONAHA.106.649236; Bouma W., Lai E.K., Levack M.M. et al. Preoperative three-dimensional valve analysis predicts recurrent ischemic mitral regurgitation after mitral annuloplasty. Ann. Thorac. Surg. 2016;101(2):567–575. DOI:10.1016/j.athoracsur.2015.09.076.; Sun X., Jiang Y., Huang G., Huang J., Shi M., Pang L. et al. Threedimensional mitral valve structure in predicting moderate ischemic mitral regurgitation improvement after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 2019;157(5):1795–1803.e2. DOI:10.1016/j.jtcvs.2018.09.018.; Sun X., Huang G., Huang J., Shi M., Wang F., Pang L. et al. Left ventricular regional dyssynchrony predicts improvements in moderate ischaemic mitral regurgitation after off-pump coronary artery bypass. Eur. J. Cardiothorac. Surg. 2018;54(1):84–90. DOI:10.1093/ejcts/ezy024.; Teng Z., Ma X., Zhang Q., Yun Y., Ma C., Hu S. et al. Additional mitral valve procedure and coronary artery bypass grafting versus isolated coronary artery bypass grafting in the management of significant functional ischemic mitral regurgitation: a meta-analysis. J. Cardiovasc. Surg. (Torino). 2017;58(1):121–130. DOI:10.23736/S0021-9509.16.08852-2.; Gelsomino S., Lorusso R., De Cicco G., Capecchi I., Rostagno C., Caciolli S. et al. Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. Eur. Heart. J. 2008;29(2):231–240. DOI:10.1093/eurheartj/ehm468.; Van Garsse L., Gelsomino S., Parise O., Lucà F., Cheriex E., Lorusso R. et al. Systolic papillary muscle dyssynchrony predicts recurrence of mitral regurgitation in patients with ischemic cardiomyopathy (ICM) undergoing mitral valve repair. Echocardiography. 2012;29(10):1191–1200. DOI:10.1111/j.1540-8175.2012.01789.x.; Gelsomino S., Lorusso R., Billè G., Rostagno C., De Cicco G., Romagnoli S. et al. Left ventricular diastolic function after restrictive mitral ring annuloplasty in chronic ischemic mitral regurgitation and its predictive value on outcome and recurrence of regurgitation. Int. J. Cardiol. 2009;132(3):419–428. DOI:10.1016/j.ijcard.2007.12.058.; Ereminiene E., Vaskelyte J., Benetis R., Stoskute N. Ischemic mitral valve repair: predictive significance of restrictive left ventricular diastolic filling. Echocardiography. 2005;22(3):217–224. DOI:10.1111/j.0742-2822.2005.03108.x.; Kongsaerepong V., Shiota M., Gillinov A.M., Song J.M., Fukuda S., Mc-Carthy P.M. et al. Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. Am. J. Cardiol. 2006;98(4):504–508. DOI:10.1016/j.amjcard.2006.02.056.; Kron I.L., Hung J., Overbey J.R., Bouchard D., Gelijns A.C., Moskowitz A.J. et al. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J. Thorac. Cardiovasc. Surg. 2015;149(3):752–61.e1. DOI:10.1016/j.jtcvs.2014.10.120.; Чернявский А.М., Разумахин Р.А., Эфендиев В.У., Рузматов Т.М., Подсосникова Т.Н. и др. Отдаленные результаты хирургического лечения умеренной ишемической митральной недостаточности у пациентов с сохраненной фракцией выброса левого желудочка. Патология кровообращения и кардиохирургия. 2015;19(2):63–71. DOI:10.21688/1681-3472-2015-2-63-71.; Smith P.K., Puskas J.D., Ascheim D.D., Voisine P., Gelijns A.C., Moskowitz A.J. et al. Surgical treatment of moderate ischemic mitral regurgitation. N. Engl. J. Med. 2014;371(23):2178–2188. DOI:10.1056/NEJMoa1410490.; El-Hag-Aly M.A., El Swaf Y.F., Elkassas M.H., Hagag M.G., Allam H.K. Moderate ischemic mitral incompetence: does it worth more ischemic time? Gen. Thorac. Cardiovasc. Surg. 2020;68(5):492–498. DOI:10.1007/s11748-019-01212-5.; Чрагян В.А., Арутюнян В.Б., Дьячков С.И. Результаты одномоментной коррекции ишемической митральной недостаточности и коронарного шунтирования у больных с осложненными формами ишемической болезни сердца. Пермский медицинский журнал. 2017;34(3):25–32. DOI:10.17816/pmj34325-32.; Salmasi M.Y., Harky A., Chowdhury M.F., Abdelnour A., Benjafield A., Suker F. et al. Should the mitral valve be repaired for moderate ischemic mitral regurgitation at the time of revascularization surgery? J. Card. Surg. 2018;33(7):374–384. DOI:10.1111/jocs.13722.; Khallaf A., Elzayadi M., Alkady H., El Naggar A. Results of coronary artery bypass grafting alone versus combined surgical revascularization and mitral repair in patients with moderate ischemic mitral regurgitation. Heart Surg. Forum. 2020;23(3):E270–E275. DOI:10.1532/hsf.2773.; Anantha Narayanan M., Aggarwal S., Reddy Y.N.V., Alla V.M., Baskaran J., Kanmanthareddy A. et al. Surgical repair of moderate ischemic mitral regurgitation – A systematic review and meta-analysis. Thorac. Cardiovasc. Surg. 2017;65(6):447–456. DOI:10.1055/s-0036-1598012.; Seese L., Deitz R., Dufendach K., Sultan I., Aranda-Michel E., Gleason T.G. et al. Midterm outcomes of isolated coronary artery bypass grafting in the setting of moderate ischemic mitral regurgitation. J. Surg. Res. 2022;278:317–324. DOI:10.1016/j.jss.2022.04.043.; Moscarelli M., Athanasiou T., Speziale G., Punjabi P.P., Malietzis G. Lancellotti P. et al. The value of adding sub-valvular procedures for chronic ischemic mitral regurgitation surgery: a meta-analysis. Perfusion. 2017;32(6):436–445. DOI:10.1177/0267659117693683.; Nappi F., Lusini M., Avtaar Singh S.S., Santana O., Chello M., Mihos C.G. Risk of ischemic mitral regurgitation recurrence after combined valvular and subvalvular repair. Ann. Thor. Surg. 2019;108(2):536–543. DOI:10.1016/j.athoracsur.2018.12.030.; Mihos C.G., Yucel E., Santana O. The role of papillary muscle approximation in mitral valve repair for the treatment of secondary mitral regurgitation. Eur. J. Card. Thorac. Surg. 2017;51(6):1023–1030. DOI:10.1093/ejcts/ezw384.; Kron I.L., Green G.R., Cope J.T. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann. Thorac. Surg. 2002;74(2):600–601. DOI:10.1016/s0003-4975(02)03749-9.; Fattouch K., Lancellotti P., Castrovinci S. Murana G., Sampognaro R., Corrado E. et al. Papillary muscle relocation in conjunction with valve annuloplasty improve repair results in severe ischemic mitral regurgitation. J. Thorac. Cardiovasc. Surg. 2012;143(6):1352–1355. DOI:10.1016/j.jtcvs.2011.09.062.; Messas E., Guerrero J.L., Handschumacher M.D., Conrad C., Chow C.M., Sullivan S. et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation. 2001;104(16):1958–1963. DOI:10.1161/hc4201.097135.; Calafiore A.M., Refaie R., Iacò A.L., Asif M., Al Shurafa H.S., Al-Amri H. et al. Chordal cutting in ischemic mitral regurgitation: a propensity-matched study. J. Thorac. Cardiovasc. Surg. 2014;148(1):41–46. DOI:10.1016/j.jtcvs.2013.07.036.; Nielsen S.L., Timek T.A., Green R.G., Dagum P., Daughters G.T., Hasenkam M.J. et al. Influence of anterior mitral leaflet second-order chordae tendineae on left ventricular systolic function. Circulation. 2003;108(4):486–491. DOI:10.1161/01.CIR.0000080504.70265.05.; Zhan-Moodie S., Xu D., Suresh K.S., He Q., Onohara D., Kalra K. et al. Papillary muscle approximation reduces systolic tethering forces and improves mitral valve closure in the repair of functional mitral regurgitation. JTCVS open. 2021;7:91–104. DOI:10.1016/j.xjon.2021.04.008.; Oi K., Arai H., Nagaoka E., Fujiwara T., Oishi K., Takeshita M. et al. Long-term outcomes of papillary muscle relocation anteriorly for functional mitral regurgitation. Interact. Cardiovasc. Thorac. Surg. 2022;35(6):ivac245. DOI:10.1093/icvts/ivac245.; https://www.sibjcem.ru/jour/article/view/2307

  8. 8
  9. 9
  10. 10
    Academic Journal

    Πηγή: Complex Issues of Cardiovascular Diseases; Том 11, № 4 (2022); 35-46 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 11, № 4 (2022); 35-46 ; 2587-9537 ; 2306-1278

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1238/712; Абдульянов И. В., Вагизов И. И., Каипов А. Э. Клинические результаты протезирования клапанов сердца двустворчатым полнопроточным механическим протезом «МедИнж-СТ». Ангиология и сосудистая хирургия. 2020; 26(4): 141-148. doi:10.33529/ANGIO2020419; Полиданов М. А., Блохин И. С. Септический эндокардит: клиника, морфологическая характеристика, протезирование клапанов. Applied science of today: problems and new approaches. Материалы Международной научно-практической конференции; 2019; 4 декабря; Петрозаводск; 2019. с. 129-137.; Энгиноев С.Т., Козьмин Д.Ю., Магомедов Г.М., Макеев С.А., Илов Н.Н.,. Чернов И.И, Тарасов Д.Г. Сравнительный анализ мини-торакотомии и стернотомии при патологии митрального клапана – опыт одного центра. Грудная и сердечно-сосудистая хирургия. 2019; 61 (4): 323-327. doi:10.24022/0236-2791-2019-61-4-323-327; Евтушенко В.В., Макогончук И.С., Евтушенко А.В. Правила и принципы отбора пациентов на хирургическое лечение приобретенных пороков сердца, осложненных фибрилляцией предсердий. Сибирский журнал клинической и экспериментальной медицины. 2017;32(3):29-34. doi:10.29001/2073-8552-2017-32-3-29-34; Клышников К.Ю., Овчаренко Е.А., Стасев А.Н., Щеглова Н.А., Одаренко Ю.Н., Халивопуло И.К., Кудрявцева Ю.А., Барбараш Л.С. In vitro исследование биологического протеза клапана для бесшовной фиксации. Вестник трансплантологии и искусственных органов. 2017;19(4):61-69. doi:10.15825/1995-1191-2017-4-61-69; Крючкова О. Н. Европейский кардиологический конгресс 2021 г., результаты основных исследований, новые клинические рекомендации. Крымский терапевтический журнал. 2021;3: 17-21.; Лакин, Г. Ф. Биометрия. М.: Высшая школа; 1990.; Малиновский Н. Н., Константинов Б. А., Дземешкевич С. Л. Биологические протезы клапанов сердца. М: Медицина; 1988.; Лебедев Д.И., Евтушенко А.В., Хорлампенко А.А. Факторы развития фибрилляции предсердий после операции на «открытом» сердце. Комплексные проблемы сердечно-сосудистых заболеваний. 2021;10(2):40-44. doi:10.17802/2306-1278-2021-10-2S-40-44; Шилкина, Н. П., Масина, И. В., Дряженкова, И. В., Виноградов, А. А., Юнонин, И. Е. Аутоиммунитет и аутовоспаление в патогенезе иммуновоспалительных заболеваний. Терапевтический архив. 2020;92(12):120-125. doi:10.26442/00403660.2020.12.200442; Евтушенко В.В., Евтушенко А.В., Павлюкова Е.Н., Суслова Т.Е., Гусакова А.М., Жилина А.Н., Курлов И.О., Попов С.В. Дисфункция синусового узла у пациентов с длительно персистирующей фибрилляцией предсердий: клинико-лабораторные параллели. Сибирский журнал клинической и экспериментальной медицины. 2021;36(1):123-128. doi:10.29001/2073-8552-2021-36-1-123-128; Кузник Б. И., Цыбиков Н. Н., Витковский Ю. А. Единая клеточно-гуморальная система защиты организма. Тромбоз, гемостаз и реология. 2005; 2 (22): 3-16.

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
    Academic Journal

    Πηγή: Diagnostic radiology and radiotherapy; Том 11, № 4 (2020); 44-51 ; Лучевая диагностика и терапия; Том 11, № 4 (2020); 44-51 ; 2079-5343

    Περιγραφή αρχείου: application/pdf

    Relation: https://radiag.bmoc-spb.ru/jour/article/view/565/443; Elliott P., Anastasakis A., Borger M., Borggrefe M.F., Cecchi F., Charron P. et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology // Eur. Heart J. 2014. Vol. 35. Р 2733-2779. doi:10.1093/eurheartj/ehu284.; Maron B.J., Maron M.S. Hypertrophic cardiomyopathy // Lancet. 2013. Vol. 381. Р. 242-255. doi:10.1016/S0140-6736(12)60397-3.; Cardim N. (Chair), Galderisi M. (Co-chair), Edvardsen T. et al. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association // Eur. Heart J. Cardiovascular Imaging. 2015. Vol. 16. Р. 280. doi:10.1093/ehjci/jeu291.; Von Knobelsdorff-Brenkenhoff F., Schulz-Menger J. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology // J. Cardiovasc. Magn. Reson. 2016. Vol. 18. Р. 6. Published 2016. Jan 22. doi:10.1186/s12968-016-0225-6.; Hoey E.T., Elassaly M., Ganeshan A., Watkin R.W., Simpson H. The role of magnetic resonance imaging in hypertrophic cardiomyopathy // Quant Imaging Med. Surg. 2014 Vol. 4 (5). Р. 397-406. doi:10.3978/j.issn.2223-4292.2014.09.04.; Chan R.H., Maron B.J., Olivotto I., Pencina M.J., Assenza G.E., Haas T.S., Lesser J.R., Gruner C., Crean A.M., Rakowski H., Udelson J.E., Rowin E.J., Lombardi M., Cecchi F., Tomberli B., Spirito P., Formisano F., Biagini E., Rapezzi C., Cecco C.N., Autore C., Cook E.F., Hong S.N., Gibson C.M., Manning W.J., Appelbaum E.A., Maron M. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy // Circulation. 2014. Vol. 130, No. 6. Р 484-495. doi: 10.116l/CIRCULATIONAHA.113.007094.; 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death // Eur. Heart J. 2015. Vol. 36. Р. 2793-2867. doi:10.1093/eurheartj/ehv316.; Рекомендации ESC по диагностике и лечению гипертрофической кардиомиопатии 2014 // Российский кардиологический журнал. 2015. № 5. С. 7-57. doi.org/10.15829/1560-4071-2015-5-7-57.; American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy // J. Am. Soc. Echocardiogr. 2011. Vol. 24. Р. 473-98. doi:10.1016/j.echo.2011.03.006.; Maron M.S., Rowin E.J., Lin D., Appelbaum E., Chan R.H., Gibson C.M., Lesser J.R., Lindberg J., Haas T.S., Udelson J.E., Manning W.J., Maron B.J. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy // Circ. Cardiovasc Imaging. 2012. Vol. 5. Р. 441-447. doi:10.1161/CIRCIMAGING.112.972760.; Deva D.P., Williams L.K., Care M., Siminovitch K.A., Moshonov H., Wintersperger B.J., Rakowski H., Crean A.M. Deep basal inferoseptal crypts occur more commonly in patients with hypertrophic cardiomyopathy due to disease-causing myofilament mutations // Radiology. 2013. Vol. 269. Р. 6876. doi:10.1148/radiol.13122344.; Moon J.C., McKenna W.J. Myocardial crypts: a prephenotypic marker of hypertrophic cardiomyopathy? // Circ. Cardiovasc. Imaging. 2012. Vol. 5. Р. 431-432. doi:10.1161/CIRCIMAGING.112.975888.; Briasoulis A., Mallikethi-Reddy S., Palla M. et al Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analy-sis // Heart. 2015. Vol. 101. Р. 1406-1411. doi:10.1136/heartjnl-2015-307682.; Freitas P., Ferreira A.M., Arteaga-Fernandez E. et al. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death // J. Cardiovasc. Magn. Reson. 2019. Vol. 21. Р. 50. doi:10.1186/s12968-019-0561-4.

  16. 16
    Academic Journal

    Πηγή: Bukovinian Medical Herald; Vol. 25 No. 1(97) (2021); 68-74 ; Буковинский медицинский вестник; Том 25 № 1(97) (2021); 68-74 ; Буковинський медичний вісник; Том 25 № 1(97) (2021); 68-74 ; 2413-0737 ; 1684-7903

    Περιγραφή αρχείου: application/pdf

  17. 17
    Academic Journal

    Πηγή: Bukovinian Medical Herald; Vol. 25 No. 1(97) (2021); 68-74
    Буковинский медицинский вестник; Том 25 № 1(97) (2021); 68-74
    Буковинський медичний вісник; Том 25 № 1(97) (2021); 68-74

    Περιγραφή αρχείου: application/pdf

    Σύνδεσμος πρόσβασης: http://e-bmv.bsmu.edu.ua/article/view/234480

  18. 18
    Academic Journal

    Συνεισφορές: Исследование выполнено в соответствии с планом НИИ кардиологии Томского НИМЦ по прикладной теме «Разработка высоких технологий хирургического лечения сердечной недостаточности и периоперационной защиты органов-мишеней» (№ AAAA-A20-120041090009-2 от 10.04.2020), а также в соответствии с планом НИИ КПССЗ по ПНИ «Сравнительный анализ безопасности и эффективности имплантации митральных биопротезов и реконструкции митрального клапана у пациентов старшей возрастной группы» (№ 419-36)

    Πηγή: Complex Issues of Cardiovascular Diseases; Том 9, № 4 (2020); 47-58 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 9, № 4 (2020); 47-58 ; 2587-9537 ; 2306-1278

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/782/527; Elliot P.M., Anastasakis A., Borger M.A., Borggrefe M., Cecchi F., Charron P, Hagege A.A., Lafont A., Limongelli G., Mahrhpldt H., McKenna W.J., Mogensen J., Nihoyannopoulos P., Nistri S., Pierper P.G., Pieske B., Rapezzi C., Rutten F.H., Tillmanns C., Watkins H. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur. Heart J. 2014; 35 (39): 2733-2779. doi:10.1093/eurheartj/ehu284.; Teo E.P., Teoh J.G., Hung J. Mitral valve and papillary muscle abnormalities in hypertrophic obstructive cardiomyopathy. Curr. Opin. Cardiol. 2015; 30 (5): 475-482. doi:10.1097/HCO.0000000000000200; Morrow A.G., Reitz B.A., Epstein S.E., Henry W.L., Conkle D.M., Itscoitz S.B., Redwood D.R. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation. 1975; 52 (1): 88-102. doi:10.1161/01.cir.52.1.88.; Konstantinos Dean Boudoulas, Harisios Boudoulas. An Evolution of Management in Hypertrophic Cardiomyopathy: Myectomy, Alcohol Septal Ablation, Mitral Valve Replacement, MitraClip. Cardiology. 2017; 137:54-57. DOI:10.1159/000455068; Kaple R.K., Murphy R.T., DiPaola L.M., Houghtaling P.L., Lever H.M., Lytle B.W., Blackstone E.H., Smedira N.G. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann. Thorac. Surg. 2008; 85 (5): 1527-1535. doi:10.1016/j. athoracsur.2008.01.061.; Смышляев К.А., Евтушенко А.В., Евтушенко В.В., Павлюкова Е.Н. Отдаленные результаты сочетанной миэктомии с пластикой митрального клапана у больных гипертрофической обструктивной кардиомиопатией. Сибирский медицинский журнал. 2016; 31 (2):82-87.; Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016; 37 (27): 2129-2200. DOI:10.1093/eurheartj/ehw128; Perier P., Clausnizer B., Mistarz K. Carpentier “Sliding leaflet” technique for repair of the mitral valve: early results. Ann. Thorac. Surg. 1994; 57 (2): 383-386. doi:10.1016/0003-4975(94)91001-4.; Bhudia S.K., McCarthy P.M., Smedira N.G., Lam B.K., Rajeswaran J., Blackstone E.H. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann. Thorac. Surg. 2004; 77 (5): 1598-1606. doi:10.1016/j.athoracsur.2003.09.090.; Ferrazzi P., Spirito P., Iacovoni A., Calabrese A., Migliorati K., Simon C., Pentiricci S., Poggio D., Grillo M., Amigoni P., Iascone M., Mortara A., Maron B.J., Senni M., Bruzzi P. Transaortic chordal cutting: mitral valve repair for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy. J. Am. Coll. Cardiol. 2015; 66 (15): 1687-1696. doi:10.1016/j.jacc.2015.07.069.; Lang R.M., Badano L.P., Mor-Avi V., Afilano J., Armstrong A., Ernande L., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J. Am. Soc. Echocardiogr. 2015; 28(1.): 1-39. DOI:10.1016/j.echo.2014.10.003; Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F., Dokainish H., Edvardsen T., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J. Am. Soc. Echocardiogr. 2016; 29 (4): 277-314. DOI:10.1016/j.echo.2016.01.011.; Zoghbi W.A., Adams D., Bonow R.O., Enriquez-Sarano M., Foster E., Grayburn P.A., et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J. Am. Soc. Echocardiogr. 2015; 30 (4): 1- 39. DOI:10.1016/j.echo.2017.01.007; Lang R.M., Badano L.P., Tsang W., Adams D.H., Agricola E., Buck T., et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J. Am. Soc. Echocardiogr. 2012; 25 (1): 3-46. DOI:10.1016/j.echo.2011.11.010

  19. 19
  20. 20
    Academic Journal

    Πηγή: Siberian Journal of Clinical and Experimental Medicine; Том 34, № 1 (2019); 69-77 ; Сибирский журнал клинической и экспериментальной медицины; Том 34, № 1 (2019); 69-77 ; 2713-265X ; 2713-2927 ; 10.29001/2073-8552-2019-34-1

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.sibjcem.ru/jour/article/view/683/428; Elliot P.M., Anastasakis A., Borger M.A., Borggrefe M., Cecchi F., Charron P., et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur. Heart J. 2014;35(39):2733–2779. DOI:10.1093/eurheartj/ehu284.; Nagueh S.F., Mahmarian J.J. Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2006;48(12):2410–2422.; Sherrid M.V., Gunsburg D.Z., Moldenhauer S., Pearle G. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2000;36(4):1344–1354.; Kaple R.K., Murphy R.T., DiPaola L.M., Houghtaling P.L., Lever H.M., Lytle B.W., et al. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann. Thorac. Surg. 2008;85(5):1527–1535. DOI:10.1016/j.athoracsur.2008.01.061.; Kim D.H., Handschumacher M.D., Levine R.A., Choi Y.S., Kim Y.J., Yun S.C., et al. In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction. Circulation. 2010;122(13):1298–1307. DOI:10.1161/CIRCULATIONAHA.109.935551.; Groarke J.D., Galazka P.Z., Cirino A.L., Lakdawaka N.K., Thune J.J., Bungaard H., et al. Intrinsic mitral valve alterations in hypertrophic sarcomere mutation carriers. Eur. Heart J. Cardiovasc. Imaging. 2018;19(10):1109–1116. DOI:10.1093/ehjci/jey095.; Cooley D.A., Wukasch D.C., Leachman R.D. Mitral valve replacement for idiopathic hypertrophic subaortic stenosis. Results in 27 patients. J. Cardiovasc. Surg. (Toronto). 1976;17(5):380–387.; Sorajja P., Pedersen W.A., Bae R., Lesser J.R., Jay D., Lin D., et al. First experience with percutaneous mitral valve plication as primary therapy for symptomatic obstructive hypertrophic сardiomyopathy. J. Am. Coll. Cardiol. 2016;67(24):2811–2818. DOI:10.1016/j.jacc.2016.03.587.; Bhudia S.K., McCarthy P.M., Smedira N.G., Lam B.K., Rajeswaran J., Blackstone E.H. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann. Thorac. Surg. 2004;77(5):1598–1606. DOI:10.1016/j.athoracsur.2003.09.090.; Balaram S.K., Ross R.E., Sherrid M.V., Schwartz G.S., Hillel Z., Winson G., et al. Role of mitral valve plication in the surgical management of hypertrophic cardiomyopathy. Ann. Thorac. Surg. 2012;94(6):1990–1997. DOI:10.1016/j.athoracsur.2012.06.008.; Hong J.H., Schaff H.V., Nishimura R.A., Abel M.D., Dearani J.A., Li Z., et al. Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures. J. Amer. Coll. Cardiol. 2016;68(14):1407–1504. DOI:10.1016/j.jacc.2016.07.735.; Yu E.H., Omran A.S., Wigle E.D., Williams W.G., Siu S.C., Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J. Am. Coll. Cardiol. 2000;36(7):2219–2225.; Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016;37(27):2129– 2200. DOI:10.1093/eurheartj/ehw128.; Williams B., Mancia G., Spiering W., Rosei E.A., Azizi M., Burnier M., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of Hypertension (ESH). Eur. Heart. J. 2018;36(10):1953–2041. DOI:10.1097/HJH.0000000000001940.; Lang R.M., Badano L.P., Mor-Avi V., Afilano J., Armstrong A., Ernande L., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J. Am. Soc. Echocardiogr. 2015;28(1):1–39. DOI:10.1016/j.echo.2014.10.003.; Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F., Dokainish H., Edvardsen T., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J. Am. Soc. Echocardiogr. 2016;29(4):277–314. DOI:10.1016/j.echo.2016.01.011.; Zoghbi W.A., Adams D., Bonow R.O., Enriquez-Sarano M., Foster E., Grayburn P.A., et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J. Am. Soc. Echocardiogr. 2015;30(4):1– 39. DOI:10.1016/j.echo.2017.01.007.; Lang R.M., Badano L.P., Tsang W., Adams D.H., Agricola E., Buck T., et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J. Am. Soc. Echocardiogr. 2012;25(1):3–46. DOI:10.1016/j.echo.2011.11.010.; Warraich H.J., Chaudary B., Maslow A., Panzica P.J., Pugsley J., Mahmood F. Mitral annular nonplanarity: correlation between annular height/commissural width ratio and the nonplanarity angle. J. Cardiothorac. Vasc. Anest. 2012;26(2):186–190. DOI:10.1161/CIRCULATIONAHA.107.749440.; Бокерия Л.А., Косарева Т.И., Макаренко В.Н., Маленков Д.А., Аносов А.А., Слепцова А.М. Анализ анатомических особенностей митрального клапана методами 2D и 3D эхокардиографии при ОГКМП. Медицинский Алфавит. 2018;14(1):34–37.; Maffessanti F., Gripari P., Pontone G., Andreini D., Bertella E., Mushtaq S., et al. Three-dimensional dynamic assessment of tricuspid and mitral annuli using cardiovascular magnetic resonance. Eur. Heart J. Cardiovasc. Imaging. 2013;14(10):986–995. DOI:10.1093/ehjci/jet004.; Кадрабулатова С.С., Павлюкова Е.Н., Карпов Р.С., Тарасов Д.Г., Ткачев И.В. Трехмерная реконструкция интактного митрального клапана с количественным анализом. Ультразвуковая и функциональная диагностика. 2013;3:54–63.; Lee A.P., Jin C.N., Fan Y., Wong R.H.L., Underwood M.J., Wan S. Functional implication of mitral annular disjunction in mitral valve prolapse: a quantitative dynamic 3D echocardiographic study. JACC Cardiovasc. Imaging. 2017;10(12):1424–1433. DOI:10.1016/j.jcmg.2016.11.022.; Кадрабулатова С.С., Павлюкова Е.Н., Карпов Р.С. Морфометрический анализ митрального клапана при болезни Барлоу (по данным трехмерной чреспищеводной эхокардиографии и количественного анализа митрального клапана). Сибирский медицинский журнал. 2013;28(3):14–19.; Dal-Bianco J.P., Levine R.A. Anatomy of the mitral valve apparatus: role of 2D and 3D echocardiography. Cardiol. Clin. 2013; 31(2): 151–164. DOI:10.1016/j.ccl.2013.03.001.; Critoph C.H., Pantazis A., Tome Esteban M.T., Salazar-Mendiguchía J., Pagourelias E.D., Moon J.C., et al. The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Open Heart. 2014;1:e000176. DOI:10.1136/openhrt-2014-000176.; Raut M., Maheshwari A., Swain B. Awareness of ‘Systolic Anterior Motion’ in Different Conditions. Clin. Med. Insights Cardiol. 2018; 12. DOI:10.1177/1179546817751921.; https://www.sibjcem.ru/jour/article/view/683